Advanced

Barriers to effective implementation of guideline recommendations.

Erhardt, Leif RW LU (2005) In Am J Med 118 Suppl 12A(12, Suppl 1). p.36-41
Abstract
Cardiovascular disease (CVD) is the leading cause of death worldwide, and its prevention and treatment are important healthcare aims. Hypercholesterolemia is among the most important modifiable Rick factors for CVD, and numerous guidelines exist for the treatment of this condition. Nevertheless, despite the existence of well-established and safe pharmacologic therapy for lowering cholesterol and preventing CVD, surveys in the United States and Europe have revealed that many patients have elevated cholesterol levels. There is a clear gap between what is known about treating CVD and the implementation of that knowledge. A survey assessing patients' knowledge about CVD observed that many patients are unaware of the disease prevalence and have... (More)
Cardiovascular disease (CVD) is the leading cause of death worldwide, and its prevention and treatment are important healthcare aims. Hypercholesterolemia is among the most important modifiable Rick factors for CVD, and numerous guidelines exist for the treatment of this condition. Nevertheless, despite the existence of well-established and safe pharmacologic therapy for lowering cholesterol and preventing CVD, surveys in the United States and Europe have revealed that many patients have elevated cholesterol levels. There is a clear gap between what is known about treating CVD and the implementation of that knowledge. A survey assessing patients' knowledge about CVD observed that many patients are unaware of the disease prevalence and have little knowledge about the main risk factors, including the importance of cholesterol. Another survey demonstrated that many physicians overestimate patients' awareness of CVD and that physicians also overestimate the extent to which guidelines are implemented in clinical practice. Guideline implementation may be improved by narrowing the discrepancies between what patients and physicians believe and the reality. Many physicians claim that lack of time hinders guideline implementation and improvement of patient education. Physicians also appear to lack the motivation to implement lipid-lowering interventions. A multifactorial approach to improving use of guidelines in clinical practice may improve the treatment and prevention of CVD. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
adherence, hypercholesterolemia, cardiovascular disease
in
Am J Med
volume
118 Suppl 12A
issue
12, Suppl 1
pages
36 - 41
publisher
Elsevier
external identifiers
  • wos:000234372000007
  • scopus:28844506125
ISSN
1555-7162
DOI
10.1016/j.amjmed.2005.09.004
language
English
LU publication?
yes
id
c9a64860-7fe6-4c90-bd02-183eacff89f6 (old id 148675)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16356806&dopt=Abstract
date added to LUP
2007-07-18 16:23:32
date last changed
2017-02-05 04:17:25
@article{c9a64860-7fe6-4c90-bd02-183eacff89f6,
  abstract     = {Cardiovascular disease (CVD) is the leading cause of death worldwide, and its prevention and treatment are important healthcare aims. Hypercholesterolemia is among the most important modifiable Rick factors for CVD, and numerous guidelines exist for the treatment of this condition. Nevertheless, despite the existence of well-established and safe pharmacologic therapy for lowering cholesterol and preventing CVD, surveys in the United States and Europe have revealed that many patients have elevated cholesterol levels. There is a clear gap between what is known about treating CVD and the implementation of that knowledge. A survey assessing patients' knowledge about CVD observed that many patients are unaware of the disease prevalence and have little knowledge about the main risk factors, including the importance of cholesterol. Another survey demonstrated that many physicians overestimate patients' awareness of CVD and that physicians also overestimate the extent to which guidelines are implemented in clinical practice. Guideline implementation may be improved by narrowing the discrepancies between what patients and physicians believe and the reality. Many physicians claim that lack of time hinders guideline implementation and improvement of patient education. Physicians also appear to lack the motivation to implement lipid-lowering interventions. A multifactorial approach to improving use of guidelines in clinical practice may improve the treatment and prevention of CVD.},
  author       = {Erhardt, Leif RW},
  issn         = {1555-7162},
  keyword      = {adherence,hypercholesterolemia,cardiovascular disease},
  language     = {eng},
  number       = {12, Suppl 1},
  pages        = {36--41},
  publisher    = {Elsevier},
  series       = {Am J Med},
  title        = {Barriers to effective implementation of guideline recommendations.},
  url          = {http://dx.doi.org/10.1016/j.amjmed.2005.09.004},
  volume       = {118 Suppl 12A},
  year         = {2005},
}